Fed Regist. 1999 Aug 18;64(159):44928-35.
The Food and Drug Administration (FDA) is publishing a guidance entitled "Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products." The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance provides guidance on general principles for the selection of test procedures and the setting and justification of acceptance criteria for biotechnological and biological products. The guidance is intended to assist in the establishment of a uniform set of international specifications for biotechnological and biological products to support new marketing applications.
美国食品药品监督管理局(FDA)正在发布一份题为“Q6B 规范:生物技术/生物制品的测试程序和验收标准”的指南。该指南是在人用药品注册技术要求国际协调会议(ICH)的主持下制定的。该指南提供了关于选择测试程序的一般原则以及生物技术和生物制品验收标准的设定和论证的指导。该指南旨在协助建立一套统一的生物技术和生物制品国际规范,以支持新的上市申请。